Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options

Table of Contents

 
  • Program Overview
    Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options
    This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms, particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other, including an Interactive Treatment Decision Support Tool, an expert-authored commentary and module, and a downloadable slideset.

Latest Content

1 of 1 Shown
  • My Thoughts on Key Myelofibrosis and Polycythemia Vera Management Studies From the Hematology 2016 Meeting

    Brady L. Stein MD, MHS - 12/30/2016 2 comments / Last Comment: 1/16/2017
    In this commentary, I highlight study findings from the 2016 Hematology meeting that may affect management of patients with myelofibrosis or polycythemia vera.
1 of 1 Shown
Show 0 More
Loading...